基于miRNA的甲状腺结节分子分类器在不确定细胞学中的开发与验证
研究开发并验证了基于细针穿刺涂片玻片的miRNA分类器mir-THYpe,用于细胞学不确定的甲状腺结节。训练集39例良性/39例恶性,验证集58例良性/37例恶性;验证集敏感度94.6%、特异度81.0%,阴性预测值95.9%,阳性预测值76.1%。
要点
- mir-THYpe可在FNA涂片玻片上检测,无需额外穿刺。
- 验证集敏感度94.6%、特异度81.0%,阴性预测值95.9%。
- 该检测有望减少不确定结节的不必要手术。
核心结论
- mir-THYpe检测在不确定甲状腺结节中具有高敏感度和较高特异度,可辅助临床决策并可能减少不必要手术。
研究设计与样本
- 研究分训练集(39例良性/39例恶性)和独立验证集(58例良性/37例恶性),均为FNA细胞学不确定的甲状腺样本。
- 从96个miRNA候选物中开发并训练mir-THYpe算法,最终使用11个miRNA。
主要发现
- 训练集10折交叉验证:敏感度89.7%、特异度92.3%、阴性预测值90.0%、阳性预测值92.1%。
- 验证集(FNA涂片玻片):敏感度94.6%、特异度81.0%、阴性预测值95.9%、阳性预测值76.1%。
- 贝叶斯定理显示mir-THYpe在广泛癌症患病率范围内表现满意。
临床怎么用
- 对于FNA细胞学不确定的甲状腺结节,可考虑使用mir-THYpe检测辅助判断良恶性。
- 该检测利用现有FNA涂片玻片,无需重复穿刺。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Thyroid nodules can be identified in up to 68% of the population. Fine-needle aspiration (FNA) cytopathology classifies 20%-30% of nodules as indeterminate, and these are often referred for surgery due to the risk of malignancy. However, histological postsurgical reports indicate that up to 84% of cases are benign, highlighting a high rate of unnecessary surgeries. We sought to develop and validate a microRNA (miRNA)-based thyroid molecular classifier for precision endocrinology (mir-THYpe) with both high sensitivity and high specificity, to be performed on the FNA cytology smear slide with no additional FNA. Methods: The expression of 96 miRNA candidates from 39 benign/39 malignant thyroid samples, (indeterminate on FNA) was analyzed to develop and train the mir-THYpe algorithm. For validation, an independent set of 58 benign/37 malignant FNA smear slides (also classified as indeterminate) was used. Results: In the training set, with a 10-fold cross-validation using only 11 miRNAs, the mir-THYpe test reached 89.7% sensitivity, 92.3% specificity, 90.0% negative predictive value and 92.1% positive predictive value. In the FNA smear slide validation set, the mir-THYpe test reached 94.6% sensitivity, 81.0% specificity, 95.9% negative predictive value, and 76.1% positive predictive value. Bayes' theorem shows that the mir-THYpe test performs satisfactorily in a wide range of cancer prevalences. Conclusions: The presented data and comparison with other commercially available tests suggest that the mir-THYpe test can be considered for use in clinical practice to support a more informed clinical decision for patients with indeterminate thyroid nodules and potentially reduce the rates of unnecessary thyroid surgeries.
引用
- Santos MTD, Buzolin AL, Gama RR, et al. Molecular Classification of Thyroid Nodules with Indeterminate Cytology: Development and Validation of a Highly Sensitive and Specific New miRNA-Based Classifier Test Using Fine-Needle Aspiration Smear Slides. Thyroid. 2018. PMID: 30319072. doi:10.1089/thy.2018.0254
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。